Cite
HARVARD Citation
Schmidt, A. et al. (2021). Treatment outcomes for patients with metastatic castrate‐resistant prostate cancer following docetaxel for hormone‐sensitive disease. Asia-Pacific journal of clinical oncology. 17 (1), pp. 36-42. [Online].